End-of-day quote
Korea S.E.
13/02/2025
5-day change
1st Jan Change
1,666.00 KRW
+2.21%
-1.54%
-8.41%
MYUNGMOON Pharm co.,Ltd's Equity Buyback announced on July 9, 2024, has expired with 98,867 shares, representing 0.29% for KRW 255.79 million.
The company expired its plan on January 9, 2025.
Tranche Update on MYUNGMOON Pharm co.,Ltd's Equity Buyback Plan announced on July 9, 2024.
09/01
CI
Tranche Update on MYUNGMOON Pharm co.,Ltd's Equity Buyback Plan announced on July 9, 2024.
09/01
CI
Tranche Update on MYUNGMOON Pharm co.,Ltd's Equity Buyback Plan announced on July 9, 2024.
09/01
CI
MYUNGMOON Pharm co.,Ltd's Equity Buyback announced on July 9, 2024, has expired with 98,867 shares, representing 0.29% for KRW 255.79 million.
09/01
CI
MYUNGMOON Pharm co.,Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024
14/11
CI
Tranche Update on MYUNGMOON Pharm co.,Ltd's Equity Buyback Plan announced on July 9, 2024.
11/24/11
CI
MYUNGMOON Pharm co.,Ltd Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024
14/24/14
CI
MYUNGMOON Pharm co.,Ltd announces an Equity Buyback for KRW 300 million worth of its shares.
09/24/09
CI
MYUNGMOON Pharm co.,Ltd authorizes a Buyback Plan.
09/24/09
CI
MYUNGMOON Pharm co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
14/24/14
CI
MYUNGMOON Pharm co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
20/24/20
CI
Tranche Update on MYUNGMOON Pharm co.,Ltd's Equity Buyback Plan announced on May 25, 2023.
27/23/27
CI
Tranche Update on MYUNGMOON Pharm co.,Ltd's Equity Buyback Plan announced on May 25, 2023.
27/23/27
CI
MYUNGMOON Pharm co.,Ltd's Equity Buyback announced on May 25, 2023, has expired with 278,592 shares, representing 0.82% for KRW 674.93 million.
25/23/25
CI
MYUNGMOON Pharm co.,Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
14/23/14
CI
Tranche Update on MYUNGMOON Pharm co.,Ltd's Equity Buyback Plan announced on May 25, 2023.
28/23/28
CI
MYUNGMOON Pharm co.,Ltd Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
11/23/11
CI
MYUNGMOON Pharm co.,Ltd announces an Equity Buyback for KRW 1,000 million worth of its shares.
25/23/25
CI
MYUNGMOON Pharm co.,Ltd authorizes a Buyback Plan.
25/23/25
CI
MYUNGMOON Pharm co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
15/23/15
CI
MYUNGMOON Pharm co.,Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
14/22/14
CI
MYUNGMOON Pharm co.,Ltd(KOSE:A017180) dropped from S&P Global BMI Index
19/22/19
CI
MYUNGMOON Pharm co.,Ltd Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
16/22/16
CI
MYUNGMOON Pharm co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022
13/22/13
CI
MYUNGMOON Pharm co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2021
15/22/15
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
A017180: Dynamic Chart
MyungMoon Pharm. Co., Ltd. is a Korea-based company mainly engaged in the manufacture of pharmaceuticals. Its products include ethical (ETC) drugs and over the counter (OTC) drugs. Its ETC drugs include anesthetic agents, digestive system drugs, rheumatoid arthritis remedies, central nervous system drugs, circulatory drugs, anti-depressant agents, anti-diabetic agents, antibiotics, hormone agents, narcotics and drugs for dermatology systems. Its OTC drugs include antinauseant agents, hepatic agents, immunologic agents, antidiarrheal agents, skin external preparations, antiallergic agents, muscle relaxants, cold drugs and parasiticides. The Company is also involved in the operation golf courses. January 2, 2012, the Company completed the merger with its wholly owned subsidiary.
More about the company
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1